EverlyWell Overview
Latest Deal Type
Series B
EverlyWell General Information
Description
Developer of testing kits intended to provide access to transparent and insightful lab tests. The company develops do-it-yourself kits for a wide range of at-home regulatory-compliant diagnostic tests including food sensitivity, fertility, hormones, STDs, thyroid and metabolism among the others, enabling users to perform tests at home and receive physician-reviewed results and insights on mobile devices.
EverlyWell Timeline
Want to dig into this profile?
We’ll help you find what you need
Learn more
EverlyWell Valuation & Funding
| Deal Type |
Date |
Amount |
Raised to Date |
Post-Val |
Status |
Stage |
| 5. Early Stage VC (Series B) |
16-Apr-2019 |
$50M |
000.00 |
00000 |
Completed |
Generating Revenue |
| 4. Seed Round |
28-Dec-2017 |
000.00 |
000.00 |
000.00 |
Completed |
Generating Revenue |
| 3. Angel (individual) |
16-Nov-2017 |
000 |
00.00 |
0000 |
Completed |
Generating Revenue |
| 2. Seed Round |
19-Apr-2016 |
$2.5M |
$2.5M |
000.00 |
Completed |
Product In Beta Test |
| 1. Accelerator/Incubator |
01-Jan-2016 |
|
|
|
Completed |
Startup |
EverlyWell Cap Table
To view EverlyWell‘s complete cap table, request access >>
| Stock |
# of Shares
Authorized |
Par Value |
Dividend Rate (%) |
Original
Issue Price |
Liquidation |
Liquidation
Pref. Multiple |
Conversion Price |
% Owned |
| Series B |
0,000,000 |
00.000000 |
00 |
00.0 |
00.0 |
00 |
00.0 |
00.000 |
| Series A-1 |
0,000,000 |
00.000000 |
00 |
00.00 |
00.00 |
00 |
00.00 |
0.000 |
| Series A |
7,926,690 |
$0.000010 |
6% |
$1.29 |
$1.29 |
1x |
$1.29 |
22.01% |
| Seed |
4,174,804 |
$0.000010 |
6% |
$0.75 |
$0.75 |
1x |
$0.75 |
11.59% |
EverlyWell Competitors (5)
| Company Name |
Financing Status |
Location |
Employees |
Total Raised |
Last Financing Date/Type |
Last Financing
Amount |
| Cerascreen |
Corporation |
Schwerin, Germany |
|
|
|
|
| 00000000000000 |
Venture Capital-Backed |
Dublin, Ireland |
000 |
00000 |
00000000000 |
00000 |
| 000000 (00000 0000 |
Venture Capital-Backed |
London, United Kingdom |
00 |
000.00 |
00000000000 |
000.00 |
| 000000 |
Venture Capital-Backed |
Boston, MA |
00 |
000.00 |
0000000000 0 |
000.00 |
| 0000 & 0000 |
Venture Capital-Backed |
San Francisco, CA |
000 |
00000 |
00000000000 |
00000 |
EverlyWell Executive Team (10)
| Name |
Title |
Board Seat |
Contact Info |
| Julia Cheek |
Founder & Chief Executive Officer |
|
|
| Joshua Stanley |
Chief Financial Officer |
|
|
| Nick Parker |
Chief Technology Officer |
|
|
| Jenifer Dasho |
Chief Marketing Officer |
|
|
| Matthew Carroll |
Vice President of Marketing |
|
|
5 Former Executives
EverlyWell Board Members (1)